经口腔前庭入路甲状腺切除术中经皮与经口神经监测策略的临床结局:2201例回顾性分析
本研究基于前瞻性收集数据库,回顾性纳入2201例经口腔前庭入路甲状腺切除术患者,比较未监测、经口监测和经皮监测三组声带麻痹发生率。
要点
- 甲状腺恶性肿瘤和Graves病/甲状腺炎为独立危险因素。
核心结论
- 经皮应用间歇联合连续术中神经监测是经口腔前庭入路甲状腺切除术中保护喉返神经的安全、可行、有效策略,可降低声带麻痹率,尤其适用于高风险甲状腺疾病患者。
研究设计与样本
- 基于前瞻性收集数据库的大规模回顾性队列研究,纳入2201例经口腔前庭入路甲状腺切除术患者。
- 比较三组:未监测组(n=109)、经口监测组(n=582,2016-2019年)、经皮监测组(n=1510,2020年至2025年5月)。
- 经口和经皮组进一步按技术分为间歇监测和联合监测(间歇+连续)。
主要发现
- 永久性声带麻痹罕见(n=2),仅发生于经口组。
临床怎么用
- 经口腔前庭入路甲状腺切除术中可考虑采用经皮联合间歇+连续神经监测以降低声带麻痹风险。
- 对甲状腺恶性肿瘤或Graves病/甲状腺炎等高危患者,经皮联合监测可能尤其获益。
局限性
- 回顾性研究设计,存在选择偏倚可能。
- 经口和经皮组的时间跨度不同(2016-2019 vs 2020-2025),可能存在学习曲线或技术演进影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recurrent laryngeal nerve palsy remains a critical complication in transoral endoscopic thyroidectomy vestibular approach. While intraoperative neuromonitoring is employed, the optimal strategy for reducing vocal cord palsy remains a topic of debate. METHODS: This large-scale, retrospective cohort study, based on a prospectively collected database, enrolled 2,201 patients who underwent transoral endoscopic thyroidectomy vestibular approach. We compared outcomes among 3 distinct groups: nonintraoperative neuromonitoring (n = 109), peroral intraoperative neuromonitoring (n = 582, year 2016-2019), and percutaneous intraoperative neuromonitoring (n = 1,510, year 2020-May 2025). The peroral and percutaneous groups were further analyzed according to the technique used: intermittent (intermittent intraoperative neuromonitoring) or combined (intermittent intraoperative neuromonitoring + continuous intraoperative neuromonitoring). End points were the incidence of vocal cord palsy and a multivariate analysis of independent risk factors for vocal cord palsy. RESULTS: The 2,092 intraoperative neuromonitoring patients (peroral and percutaneous) were analyzed in 4 subgroups: peroral intermittent intraoperative neuromonitoring (n = 481), peroral combined (intermittent intraoperative neuromonitoring + continuous intraoperative neuromonitoring, n = 101), percutaneous intermittent intraoperative neuromonitoring (n = 1,100), and percutaneous combined (intermittent intraoperative neuromonitoring + continuous intraoperative neuromonitoring, n = 410). Among these, the percutaneous combination (percutaneous-combined) group had a significantly lower temporary vocal cord palsy rate (0.2%) than all other groups (P < .05). This was attributed to higher technical success: percutaneous-combined intraoperative neuromonitoring achieved higher rates of persistent vagus nerve stimulation (99.7% vs 94.4%), a higher detection rate of imminent recurrent laryngeal nerve injury (4.4% vs 0.7%, P < .05), and a higher intraoperative signal recovery rate (88.9% vs 33.3%). Permanent vocal cord palsy was rare (n = 2), occurring only in the peroral groups. Critically, multivariate analysis confirmed that percutaneous combination intraoperative neuromonitoring was an independent protective factor against vocal cord palsy (odds ratio, 0.08; P = .02), whereas thyroid malignancy (odds ratio, 2.02; P = .02) and Graves disease/thyroiditis (odds ratio, 2.19; P = .03) were 2 independent risk factors. CONCLUSION: This large-scale study confirms that the percutaneous application of combined intermittent intraoperative neuromonitoring and continuous intraoperative neuromonitoring is a safe, feasible, and effective strategy for protecting the recurrent laryngeal nerve in the transoral endoscopic thyroidectomy vestibular approach. It is associated with reduced vocal cord palsy rates and can be considered a viable option, especially for individuals with high-risk thyroid diseases.
引用
- Uen YH, Wu CW, Wen KS, et al. Clinical outcomes of percutaneous versus peroral intraoperative neuromonitoring strategies in transoral endoscopic thyroidectomy vestibular approach: A retrospective analysis of 2,201 patients. Surgery. 2026. PMID: 42475946. doi:10.1016/j.surg.2026.110432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。